Abstract
Andrew Bottomley’s background includes studies as a psychologist in the UK, where he obtained a PhD by examining the impact of group psychological interventions on cancer patients’ health-related quality of life (HRQoL). Dr Bottomley’s passion for more than the last decade and a half has been to understand the consequences of cancer and its treatment on patients’ HRQoL. Since 1998 he has led the European Organisation for Treatment of Cancer (EORTC) Quality of Life Department, based in Brussels, Belgium. Dr Bottomley serves on numerous Editorial Boards. He also serves on the Ethical Committee of the WHO International Agency for Research in Cancer, in Lyon, France, and has served as a scientific advisor the European Commission for the 7th Framework program as well as an ethical advisor for the framework. He is a founding member of the Cochrane collaboration HRQoL methods group.
Financial & competing interests disclosure
The author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.